SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the performance and application of its Saphyr system for optical genome mapping are being ...

SAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that optical genome mapping (OGM) was extensively featured across a wide range of talks and ...

SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced optical genome mapping (OGM) reveals new insights and prognostic capabilities compared to ...

SAN DIEGO, April 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the launch of an IRB-approved preclinical evaluation study using optical genome mapping (OGM ...

Bionano announced a significant study published in the American Journal of Hematology demonstrating the utility of optical genome mapping (OGM) in detecting structural variants associated with ...

Nevertheless, with its focus on "optical genome mapping" ("OGM") and "Structural Variation Analysis" Bionano believes that its Saphyr system offers a greater breadth of services and more ...

Slide from Bionano investor presentation showing complexity of current cytogenetic workflow. Saphyr uses a technique known as Optical Genome Mapping to identify Structural Variations ("SVs") i.e ...

Still, NGM technology has come a long way since Bionano’s founding in 2003, and continues to improve. Saphyr is the company’s second-generation optical mapping system, processing samples 10 ...

As part of a sponsored spotlight panel, Bionano’s chief medical officer, Dr. Alka Chaubey, will host a discussion titled “Unleashing Genomic Insights That Matter with Optical Genomic Mapping ...

CEO Erik Holmlin highlighted a strategic shift toward optimizing the utilization of existing optical genome mapping (OGM ... from $27.4 million in Q4 2023. Bionano projects full-year 2025 revenues ...